Evidence map›Paper›PMID 31581627›Full record

ArticleMolecules (Basel, Switzerland)2019

Comparative Study of Aryl

Leila Mousavifar, Gérard Vergoten, Guillaume Charron, René Roy

Open access · goldAbstract readComparative Study
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Lectin andMolecules (Basel, Switzerland) · 2021
    Article
  5. Review
  6. d-Mannose Treatment neither Affects UropathogenicMolecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Leila MousavifarDepartment of Chemistry, Université du Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, Québec H3C 3P8, Canada. Leilyanmousavifar@gmail.com.ORCID 0000-0003-2187-7592
Gérard VergotenUnité de Glycobiologie Structurale et Fonctionnelle (UGSF), UMR8576 du CNRS, Université de Lille, F-59000 Lille, France. Gerard.vergoten@univ-lille.fr.
Guillaume CharronDepartment of Chemistry, Université du Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, Québec H3C 3P8, Canada. charronguy@hotmail.com.
René RoyDepartment of Chemistry, Université du Québec à Montréal, P.O. Box 8888, Succ. Centre-Ville, Montréal, Québec H3C 3P8, Canada. roy.rene@uqam.ca.ORCID 0000-0001-5638-7302
Université du Québec à Montréal · CACentre National de la Recherche Scientifique · FR

Funding

FQRNT 2018-PR-206987Natural Sciences and Engineering Research Council of Canada 317417Natural Sciences and Engineering Research Council of Canada 371417
6 · The paper itself

Abstract

A set of three mannopyranoside possessing identical 1,1'-biphenyl glycosidic pharmacophore but different aglyconic atoms were synthesized using either a palladium-catalyzed Heck cross coupling reaction or a metathesis reaction between their corresponding allylic glycoside derivatives. Their X-ray structures, together with their calculated 3D structures, showed strong indicators to explain the observed relative binding abilities against

Indexed as

Adhesins, Escherichia coliBacterial AdhesionCarbohydrate ConformationFimbriae ProteinsGene Expression Regulation, BacterialHexosesModels, MolecularSurface Plasmon ResonanceUropathogenic Escherichia coliAdhesins, Escherichia coliFimbriae ProteinsfimH protein, E coliHexosescarbohydrateD-mannosidesE. coliFimHHeck reactionlectinmetathesisSPRuropathogenic infectionsX-ray

Identifiers

PMID31581627
PMCPMC6804135
OpenAlexW2979177755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.